NCT04333108 2023-05-06
Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis Unresponsive to Optimal Symptomatic Treatment
AB Science
Phase 3 Unknown
Clinical Trials
4 trialsNCT00814073 2019-12-03
AB06006
AB Science
Phase 3 Completed
NCT00831974 2018-12-11
Efficacy of AB1010 in Patients With Systemic Indolent Mastocytosis
AB Science
Phase 2 Completed
NCT01266369 2018-12-10
Masitinib in Patients With Mastocytosis With Handicap and Bearing the D816V Mutation
AB Science
Phase 2 Completed